Description
+ Include: 18 videos + 19 pdfs, size: 1.48 GB
+ Target Audience: oncologist, immunologist
+ Sample video: contact me for sample video
+ Information:
- Start date: 17 Nov 2023
- End date: 18 Nov 2023
- Location: Zurich, Switzerland
Learning objectives
- To understand the concept of biomarker driven treatment
- To gain insights into the technical and clinical aspects of biomarker testing
- To understand the clinical implications of molecularly guided therapy options
- To integrate this knowledge into clinical decision making
+ Topics:
ESMO-Advanced-Course-on-Biomarkers-for-Precision-Immuno-Oncology-Across-Tumours-2023-Zurich-Programme.pdf.pdf
Session 1 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.mp4
Session 1 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.pdf
Session 1 Biology of the Target Biomarkers (Function and Roles in Normal and Tumour Tissue Homeostasis).mp4
Session 1 Biology of the Target Biomarkers (Function and Roles in Normal and Tumour Tissue Homeostasis).pdf
Session 1 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).mp4
Session 1 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).pdf
Session 1 Update on The Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.mp4
Session 1 Update on The Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.pdf
Session 2 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.mp4
Session 2 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.pdf
Session 2 Biology of the Target Biomarkers (Function and Roles in Normal and Tumour Tissue Homeostasis).mp4
Session 2 Biology of the Target Biomarkers (Function and Roles in Normal and Tumour Tissue Homeostasis).pdf
Session 2 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).mp4
Session 2 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).pdf
Session 2 Update on The Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.mp4
Session 2 Update on The Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.pdf
Session 3 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.mp4
Session 3 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.pdf
Session 3 Biology of the Target Biomarkers (Function and Roles in Normal and Tumour Tissue Homeostasis).mp4
Session 3 Biology of the Target Biomarkers (Function and Roles in Normal and Tumour Tissue Homeostasis).pdf
Session 3 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).mp4
Session 3 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).pdf
Session 3 Update on The Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.mp4
Session 3 Update on The Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.pdf
Session 4 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.mp4
Session 4 A Clinicopathological Case Presented and Discussed by a Molecular Tumour Board.pdf
Session 4 Biology of the Target Biomarkers (Function and Roles in Normal and Tumour Tissue Homeostasis).mp4
Session 4 Biology of the Target Biomarkers (Function and Roles in Normal and Tumour Tissue Homeostasis).pdf
Session 4 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).mp4
Session 4 Testing for the Target Biomarker (Assays, Technicalities and Practicalities, Challenges for Interpretation).pdf
Session 4 Update on The Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.mp4
Session 4 Update on The Clinical Efficacy of Approved Targeted Agents Formal Indications, Efficacy and Toxicity.pdf
Session 4 Value Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD).mp4
Session 4 Value Health Economics of Testing and Targeting (Incl. MCBS, ESCAT Actionability, RWD).pdf
Welcome and Introduction.mp4
Welcome and Introduction.pdf
Reviews
There are no reviews yet.